Genetic Engineering & Biotechnology News

MAY1 2015

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link:

Contents of this Issue


Page 30 of 45

Ben Schroeder, Ph.D. Senior Scientist NuGEN Technologies Steve Kain, Ph.D. Director of Product Marketing NuGEN Technologies Tuesday May 5, 2015 11: 00 am ET 8: 00 am PT DURATION 60 minutes COST Complimentary Speakers John Sterling Editor in Chief GEN Moderator A Novel Approach to Epigenetic Methylation Analysis Free Registration! Altered DNA methylation is an important regulator of gene expression contributing to a wide range of normal and disease phenotypes. While the number of whole genome bisulfte sequencing studies is rapidly growing, the sequencing costs associated with such studies can be quite large. Reduced Representation Bisulfte Sequencing (RRBS) allows researchers to obtain quantitative DNA methylation information across many important features of the genome with approximately 50-fold fewer sequencing reads than are needed with whole genome bisulfte sequencing, resulting in substantial sequencing cost reduction. During this webinar we will describe and present data from a novel approach to RRBS. The Ovation® RRBS Methyl-Seq System can be used to generate RRBS libraries suitable for sequencing on Illumina platforms in a single day using 100 ng of human genomic DNA without gel-based size selection. The approach overcomes two challenges traditionally associated with the RRBS approach, namely the problem of low base diversity and the inability to identify PCR duplicates. Both problems have now been surmounted, allowing researchers to easily generate high-quality RRBS data. A live Q&A session will follow the presentation, ofering you a chance to pose questions to our expert panelists. You Will Learn • How RRBS can be used as a cost-efective method to survey samples for diferential DNA methylation. • How the Ovation RRBS Methyl-Seq System overcomes the problem of low base diversity and eliminates the need for PhiX controls. • How the duplicate-marking capability used in the Ovation RRBS Methyl-Seq System enables an important data quality control, especially when working with limited or degraded samples. Who Should Attend • Cancer researchers • R&D scientists • Clinical research and development scientists • Researchers interested in epigenetics Webinars Produced with support from

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - MAY1 2015